E-LIB Suche - Ergebnisse für: Kim, Joo-Hang

1

Lazertinib as a frontline treatment in patients with EGFR-m..:

Chul Cho, Byoung ; Han, Ji-Youn ; Hyeong Lee, Ki...
Lung Cancer. 190 (2024) - p. 107509 , 2024

Link: https://doi.org/10.1016/..

2

Lazertinib versus Gefitinib as First-Line Treatment for EGF..:

Lee, Ki Hyeong ; Cho, Byoung Chul ; Ahn, Myung-Ju...
Cancer Research and Treatment. 56 (2024) 1 - p. 48-60 , 2024

Link: https://doi.org/10.4143/..

3

Characterization of virus-mediated autoimmunity and the con..:

Kim, Ahreum ; Choi, Sung Jae ; Song, Gwan Gyu..
Clinical Rheumatology. 42 (2023) 10 - p. 2799-2809 , 2023

Link: https://doi.org/10.1007/..

4

A Phase 2 Study of Palbociclib for Recurrent or Refractory ..:

Jung, Hyun Ae ; Kim, Miso ; Kim, Hae Su...
Journal of Thoracic Oncology. 18 (2023) 2 - p. 223-231 , 2023

Link: https://doi.org/10.1016/..

5

Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in T..:

Reungwetwattana, Thanyanan ; Cho, Byoung Chul ; Lee, Ki Hyeong...
Journal of Thoracic Oncology. 18 (2023) 10 - p. 1351-1361 , 2023

Link: https://doi.org/10.1016/..

6

Central Nervous System Outcomes of Lazertinib Versus Gefiti..:

Soo, Ross A. ; Cho, Byoung Chul ; Kim, Joo-Hang...
Journal of Thoracic Oncology. 18 (2023) 12 - p. 1756-1766 , 2023

Link: https://doi.org/10.1016/..

7

The Development of AXL Inhibitors in Lung Cancer: Recent Pr..:

Sang, Yun Beom ; Kim, Joo-Hang ; Kim, Chang-Gon...
Frontiers in Oncology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

8

A Phase 1/2 Study of Lazertinib 240 mg in Patients With Adv..:

Cho, Byoung Chul ; Han, Ji-Youn ; Kim, Sang-We...
Journal of Thoracic Oncology. 17 (2022) 4 - p. 558-567 , 2022

Link: https://doi.org/10.1016/..

9

Integrative Genomic and Transcriptomic Analyses of Tumor Su..:

Kim, Ahreum ; Lim, Sun Min ; Kim, Joo-Hang.
Frontiers in Immunology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

10

Colonic Perforation After Treatment With Nivolumab in Esoph..:

Cho, Hye Jung ; Kim, Woo Ram ; Kim, Joo-Hang...
Annals of Coloproctology. 37 (2021) Suppl 1 - p. S39-S43 , 2021

Link: https://doi.org/10.3393/..

11

Comprehensive Analysis of Mutation-Based and Expressed Gene..:

Keam, Bhumsuk ; Park, Jin-Young ; Kim, Jin-Pyo...
Processes. 9 (2021) 5 - p. 792 , 2021

Link: https://doi.org/10.3390/..

12

An open-label expanded access program of afatinib in EGFR t..:

Park, Keunchil ; Kim, Jin-Soo ; Kim, Joo-Hang...
BMC Cancer. 21 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

13

Final overall survival and safety update for durvalumab in ..:

Garassino, Marina Chiara ; Cho, Byoung-Chul ; Kim, Joo-Hang...
Lung Cancer. 147 (2020) - p. 137-142 , 2020

Link: https://doi.org/10.1016/..

14

Antitumor effects of IL-12 and GM-CSF co-expressed in an en..:

Kim, Kyoung-Ju ; Moon, Dahye ; Kong, So Jung...
Gene Therapy. 28 (2020) 3-4 - p. 186-198 , 2020

Link: https://doi.org/10.1038/..

15

Exploratory analysis of front-line therapies in REVEL: a ra..:

Garon, Edward B. ; Scagliotti, Giorgio Vittorio ; Gautschi, Oliver...
ESMO Open. 5 (2020) 1 - p. e000567 , 2020

Link: https://doi.org/10.1136/..